Comparing Rituximab vs Ruxience
| Rituximab | Ruxience (rituximab) |
|
|---|
| Rituximab | Ruxience (rituximab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Rituximab (brand name Rituxan) is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia... View more |
Prescription only
Prescribed for Follicular Lymphoma, Granulomatosis with Polyangiitis, Chronic Lymphocytic Leukemia, Microscopic Polyangiitis, Non-Hodgkin's Lymphoma. Ruxience may also be used for purposes not listed... View more |
Related suggestions Non-Hodgkin's Lymphoma
Granulomatosis with Polyangiitis
|
|||||||
| More about Rituximab | More about Ruxience (rituximab) | ||||||||
| Ratings & Reviews | |||||||||
|
Rituximab has an average rating of 7.7 out of 10 from a total of 168 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 14% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Rituximab side effects |
View all Ruxience side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ruxience prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Riabni, Rituxan, Ruxience, Truxima | Other rituximab brands include: Riabni, Rituxan, Truxima | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
59.8 hours |
59.8 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 192 drugs are known to interact with Rituximab:
|
A total of 192 drugs are known to interact with Ruxience:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
July 23, 2019 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.